Table 3.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Approach | ||||
ODP | Ref | |||
RDP | 0.165 (0.117, 0.233) | < 0.001 | 0.239 (0.158, 0.361) | < 0.001 |
Age | 1.014 (1.004, 1.024) | 0.008 | 1.015 (1.001, 1.029) | 0.033 |
Sex | ||||
Male | Ref | |||
Female | 0.696 (0.506, 0.956) | 0.025 | 0.823 (0.537, 1.260) | 0.370 |
BMI | 0.984 (0.945, 1.024) | 0.428 | ||
ALB | 0.956 (0.926, 0.988) | 0.007 | 0.990 (0.948, 1.034) | 0.647 |
Abdominal surgery history | 1.047 (0.651, 1.683) | 0.850 | ||
ASA score | ||||
1 | Ref | |||
2 | 1.072 (0.756, 1.520) | 0.695 | ||
3 | 2.002 (0.875, 4.579) | 0.100 | ||
CA 19-9 (IU/L) | ||||
≤ 35 | Ref | |||
> 35 | 2.296 (1.194, 4.416) | 0.013 | 1.696 (0.785, 3.666) | 0.179 |
PV/SMV abutment | 3.456 (0.943,12.669) | 0.061 | ||
Tumor size | 1.283 (1.192, 1.381) | < 0.001 | 1.283 (1.173, 1.404) | < 0.001 |
Pathology | ||||
Cystic neoplasm | Ref | |||
Solid neoplasm (SPT and PNET) | 1.312 (0.921, 1.868) | 0.133 | 1.634 (1.043, 2.560) | 0.032 |
IPMN | 1.608 (0.957, 2.703) | 0.073 | 1.565 (0.827, 2.962) | 0.169 |
Inflammatory neoplasm | 6.939 (3.388,14.214) | < 0.001 | 5.121 (2.220, 11.811) | < 0.001 |
Others | 1.113 (0.572, 2.165) | 0.752 | 0.884 (0.386, 2.027) | 0.771 |
Tumor location | ||||
Tail | Ref | |||
Body–tail junction | 1.051 (0.697, 1.585) | 0.813 | ||
Body and neck | 1.108 (0.791, 1.551) | 0.551 | ||
Operative time | 1.008 (1.005, 1.011) | < 0.001 | 0.998 (0.994, 1.002) | 0.245 |
Estimated blood loss | 1.004 (1.003, 1.005) | < 0.001 | 1.003 (1.001, 1.004) | < 0.001 |
P values < 0.05 indicate a significant difference between the two groups are given in bold